Ftse Mib
33.414,56
0,46%
DAX
19.626,45
1,05%
S&P 500
6.032,38
0,56%
NASDAQ
19.218,17
0,83%
Bitcoin
96.732,20
-0,77%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Alexion Pharmaceuticals Inc (ALXN) Alexion Pharmaceuticals Inc (ALXN) Notizie

ALXN

Alexion Pharmaceuticals (ALXN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ALXN
DataOraFonteTitoloSimboloCompagnia
28/07/202310:54KR Market News알렉시온, 화이자 유전자 치료제를 10억 달러 인수 합의NASDAQ:ALXNAlexion Pharmaceuticals Inc
28/07/202310:23KR Market News아스트라제네카, 항암제 수요로 2분기 결과 예상치 상회NASDAQ:ALXNAlexion Pharmaceuticals Inc
26/07/202112:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ALXNAlexion Pharmaceuticals Inc
23/07/202122:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
22/07/202115:09Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ALXNAlexion Pharmaceuticals Inc
22/07/202112:27Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALXNAlexion Pharmaceuticals Inc
21/07/202115:12Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ALXNAlexion Pharmaceuticals Inc
16/07/202101:01PR Newswire (US)Moderna Set to Join S&P 500NASDAQ:ALXNAlexion Pharmaceuticals Inc
15/07/202122:05Business WireAlexion Announces Positive Topline Results from Phase 3 Study of ULTOMIRIS® (ravulizumab-cwvz) in Adults with Generalized My...NASDAQ:ALXNAlexion Pharmaceuticals Inc
15/07/202102:00GlobeNewswire Inc.Honeywell International Inc. to Join the NASDAQ-100 Index Beginning July 21, 2021NASDAQ:ALXNAlexion Pharmaceuticals Inc
14/07/202118:13Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ALXNAlexion Pharmaceuticals Inc
14/07/202111:11Dow Jones NewsAstraZeneca Says $39 Billion Alexion Deal Set for Completion After UK Clearance -- UpdateNASDAQ:ALXNAlexion Pharmaceuticals Inc
14/07/202108:30Dow Jones NewsUK Regulator Clears AstraZeneca's Alexion DealNASDAQ:ALXNAlexion Pharmaceuticals Inc
11/06/202109:01Business WireCaelum & Alexion Present Additional Phase 2 Data Reinforcing Safety & Tolerability of CAEL-101 in AL Amyloidosis at the Europ...NASDAQ:ALXNAlexion Pharmaceuticals Inc
07/06/202119:55Business Wire Alexion Announces FDA Approval of ULTOMIRIS® (ravulizumab-cwvz) for Children & Adolescents with Paroxysmal Nocturnal Hemog...NASDAQ:ALXNAlexion Pharmaceuticals Inc
04/06/202122:22Dow Jones NewsAstraZeneca Taps Alexion Executive for CFO Job -- UpdateNASDAQ:ALXNAlexion Pharmaceuticals Inc
04/06/202108:40Dow Jones NewsAstraZeneca Names Aradhana Sarin as Next CFONASDAQ:ALXNAlexion Pharmaceuticals Inc
27/05/202108:43Dow Jones NewsAstraZeneca Prices EUR800 Million Bond OfferingNASDAQ:ALXNAlexion Pharmaceuticals Inc
26/05/202108:43Dow Jones NewsAstraZeneca Prices $7 Billion Bond Offering to Partly Fund Alexion AcquisitionNASDAQ:ALXNAlexion Pharmaceuticals Inc
25/05/202108:41Dow Jones NewsUK Watchdog Starts Investigation Into AstraZeneca's Acquisition of AlexionNASDAQ:ALXNAlexion Pharmaceuticals Inc
13/05/202114:06Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ALXNAlexion Pharmaceuticals Inc
12/05/202122:14Business WireCaelum and Alexion Announce Upcoming CAEL-101 Data Presentations at the European Hematology Association Congress 2021NASDAQ:ALXNAlexion Pharmaceuticals Inc
12/05/202122:01Business WireAlexion Announces Upcoming Data Presentations at the 26th European Hematology Association Virtual CongressNASDAQ:ALXNAlexion Pharmaceuticals Inc
12/05/202110:52TipRanksAlexion Investors Approve Acquisition By AstraZenecaNASDAQ:ALXNAlexion Pharmaceuticals Inc
11/05/202122:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALXNAlexion Pharmaceuticals Inc
11/05/202115:28Business WireAlexion Shareholders Approve Acquisition by AstraZenecaNASDAQ:ALXNAlexion Pharmaceuticals Inc
30/04/202114:27Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ALXNAlexion Pharmaceuticals Inc
30/04/202114:00Business WireAlexion Reports First Quarter 2021 ResultsNASDAQ:ALXNAlexion Pharmaceuticals Inc
28/04/202123:00Business WireUPDATED Alexion to Report First Quarter 2021 Results on Friday, April 30, 2021NASDAQ:ALXNAlexion Pharmaceuticals Inc
20/04/202114:00Business WireAlexion to Report First Quarter 2021 Results on Monday, May 3, 2021NASDAQ:ALXNAlexion Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ALXN

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
BAMI
Banco BPM
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
TIT
Telecom Italia
BIT
MONC
Moncler
BIT
TEN
Tenaris
BIT
RACE
Ferrari NV
BIT
MB
Mediobanca Banca di Cred...
BIT
G
Generali
BIT
BPE
Bper Banca
BIT
SPM
Saipem
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network